The Company has three stock-based compensation plans currently in effect as of December 31, 2023, as described further below. Total compensation cost that has been charged against earnings for these plans for the years ended December 31, 2023, 2022 and 2021 was $1.3 million, $1.2 million and $558 thousand, respectively.

2005 Plan: In 2005, the Board of Directors and shareholders of the Bank approved a stock option plan for the benefit of directors and employees of the Bank (the “2005 Plan”). The 2005 Plan was assumed by the Company in 2016 at the time of the bank holding company reorganization. Under the 2005 Plan, the Bank was authorized to grant options to purchase up to 770,000 shares of the Company’s common stock.

The exercise prices of the options may not be less than 100% of the fair value of the Company’s common stock at the date of grant. The options, when granted, vest either immediately or ratably over five years from the date of the grant and expire after ten years if not exercised. The 2005 Plan expired in 2015, and no future grants can be made under the 2005 Plan.



($ in thousands, except share data)	Number of Options Outstanding	Weighted Average Exercise Price		Aggregate Intrinsic Value
Outstanding, as of January 1, 2023	30,000	$	6.18	$	149
Options granted	—	—
Options exercised	(30,000)	6.18
Options forfeited	—	—
Options expired	—	—
Outstanding, as of December 31, 2023	—	$	—	$	—
Fully vested and expected to vest	—	$	—	$	—
Vested	—	$	—	$	—



	Year Ended December 31,
($ in thousands)		2023		2022		2021
Intrinsic value of options exercised		$	86	$	113	$	231
Cash received from option exercises		128		128		64
Tax benefit realized from option exercised		2		2		27

2010 Plan: In 2010, the Board of Directors of the Bank approved a new equity incentive plan for granting stock options and restricted stock awards to key employees, officers, and non-employee directors of the Bank (the “2010 Plan”). In 2013, the 2010 Plan was amended and approved by the shareholders to increase the number of shares authorized to be issued under from 1,350,000 shares to 2,500,000 shares of common stock. The 2010 Plan was assumed by the Company in 2016 at the time of the bank holding company reorganization.

The exercise prices of stock options granted under the plan may not be less than 100% of the fair value of the Company’s stock at the date of grant. The options, when granted, vest ratably over five years from the date of the grant and expire after ten years if not exercised. The 2010 Plan expired in August 2020, and no further grants can be made under the 2010 Plan.

Restricted stock awards issued under the 2010 Plan may or may not be subject to vesting provisions. Owners of the restricted stock awards shall have all of the rights of a shareholder including the right to vote the shares and to all

dividends (cash or stock). Compensation expense related to restricted stock awards will be recognized over the vesting period of the awards based on the fair value of the Company’s common stock at the issue date.

A summary of the stock options outstanding under the 2010 Plan for the year ended December 31, 2023 is as follows:



($ in thousands, except share data)	Number of Options Outstanding	Weighted Average Exercise Price		Aggregate Intrinsic Value
Outstanding, as of January 1, 2023	150,000	$	8.00	$	474
Options granted	—	—
Options exercised	(90,000)	8.00
Options forfeited	—	—
Options expired	—	—
Outstanding, as of December 31, 2023	60,000	$	8.00	$	177
Fully vested and expected to vest	60,000	$	8.00	$	177
Vested	60,000	$	8.00	$	177



	Year Ended December 31,
($ in thousands)		2023		2022		2021
Intrinsic value of options exercised		$	186	$	224	$	86
Cash received from option exercises		720		480		25
Tax provision realized from option exercised		(3)		—		—

The weighted average remaining contractual term of stock options outstanding as of December 31, 2023 was 0.3 years. The weighted average remaining contractual term of stock options that were exercisable as of December 31, 2023 was 0.3 years.

A summary of the changes in the Company's non-vested restricted stock awards under the 2010 Plan for the year ended December 31, 2023 is as follows:



($ in thousands, except share data)	Shares Issued	Weighted Average Grant Date Fair Value		Aggregate Intrinsic Value
Non-vested, as of January 1, 2023	14,500	$	8.66	$	162
Awards granted	—	—
Awards vested	(4,500)	6.37
Awards forfeited	—	—
Non-vested, as of December 31, 2023	10,000	$	9.69	$	110

Information related to vested restricted stock awards under the 2010 Plan for the periods indicated follows:



	Year Ended December 31,
		2023		2022		2021
Tax benefit (provision) realized from awards vested		$	4	$	—	$	(85)

As of December 31, 2023, the Company had approximately $18 thousand of unrecognized compensation cost related to unvested restricted stock awards under the 2010 Plan. The Company expects to recognize these costs over a weighted average period of 0.9 years.

2021 Plan: In 2021, the Board of Directors of the Company approved a new equity incentive plan for granting stock options and restricted stock awards to key employees, officers, and non-employee directors of the Company and the Bank (the “2021 Plan”). The 2021 Plan was approved by the Company’s shareholders at the 2021 Annual Meeting. The number of shares authorized to be issued under the 2021 Plan was 1,500,000 shares of the Company’s common stock.

The exercise prices of stock options granted under the plan may not be less than 100.00% of the fair value of the Company’s stock at the date of grant. There are no stock options granted under the 2021 Plan as of December 31, 2023.

Restricted stock awards issued under the 2021 Plan may or may not be subject to vesting provisions. Owners of the restricted stock awards shall have all rights of a shareholder including the right to vote the shares and to all dividends (cash or stock). Compensation expense related to restricted stock awards will be recognized over the vesting period of the awards based on the fair value of the Company’s common stock at the issue date.

A summary of the changes in the Company’s non-vested restricted stock awards under the 2021 Plan for the year ended December 31, 2023 is as follows:



($ in thousands, except share data)	Shares Issued	Weighted Average Grant Date Fair Value		Aggregate Intrinsic Value
Non-vested, as of January 1, 2023	317,366	$	11.60	$	3,542
Awards granted	36,280	8.35
Awards vested	(67,295)	10.33
Awards forfeited	(7,500)	12.90
Non-vested, as of December 31, 2023	278,851	$	11.45	$	3,053

Information related to vested restricted stock awards under the 2021 Plan for the periods indicated follows:



	Year Ended December 31,
($ in thousands)		2023		2022		2021
Tax benefit (provision) realized from awards vested		$	(34)	$	12	$	—

There were 1,111,457 shares available for future grants of either stock options or restricted stock awards under the 2021 Plan as of December 31, 2023. The Company had approximately $1.7 million of unrecognized compensation cost related to unvested restricted stock awards under the 2021 Plan as of December 31, 2023. The Company expects to recognize these costs over a weighted average period of 1.6 years.